Cecilia Jones Logic Bio Therapeutics, Inc. (LOGC) insider trading activity

LOGC Quotes by TradingView

Cecilia Jones is Chief Financial Officer of LogicBio Therapeutics, Inc.. Currently has a direct ownership of 3,764 shares of LOGC, which is worth approximately $0. The most recent transaction as insider was on Jan 12, 2022, when has been sold 2,175 shares (Common Stock) at a price of $2.01 per share, resulting in proceeds of $4,372. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.76K
0% 3M change
0% 12M change
Total Value Held $0

Cecilia Jones Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 12 2022
SELL
Payment of exercise price or tax liability
$4,372 $2.01 p/Share
2,175 Reduced 36.62%
3,764 Common Stock
Jan 11 2022
BUY
Exercise of conversion of derivative security
-
5,939 Added 50.0%
5,939 Common Stock

Also insider at

AGIO
AGIOS PHARMACEUTICALS, INC. Healthcare
Chief Financial Officer
CJ

Cecilia Jones

Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on LOGC

Follow LogicBio Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LOGC shares.

Notify only if

Insider Trading

Get notified when an Logic Bio Therapeutics, Inc. insider buys or sells LOGC shares.

Notify only if

News

Receive news related to LogicBio Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LOGC